$ 31,869$ 30,209$ 1,6605%Assays and related products
53,20048,7274,4739%Operating income (loss)Technology and strategic partnerships
7,6817,2304516%Assays and related products
(9,233)(1,622)(7,611)-469%Total Operating income (loss)
(1,552)5,608(7,160)-128%FINANCIAL OUTLOOK AND GUIDANCE The Company reaffirms its 2013 annual revenue guidance of between $220 and $230 million.
CONFERENCE CALL Management will host a conference call to discuss the operating highlights and financial results for the first quarter ended March 31, 2013, on Monday, April 29, 2013, at 4:00 p.m. Central time/ 5:00 p.m. Eastern time. The conference call will be webcast live and will be accompanied by a slide presentation, both of which may be accessed at Luminex Corporation's website at http://www.luminexcorp.com. Simply log on to the web at the address above, go to the Company section and access the Investor Relations link. Please go to the website at least 15 minutes prior to the call to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the call and slides will be archived for six months on the website using the 'replay' link.
Luminex develops, manufactures and markets proprietary biological testing technologies with applications throughout the life sciences industry. The Company's xMAP system
|SOURCE Luminex Corporation|
Copyright©2012 PR Newswire.
All rights reserved